+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vascular Imaging - Global Strategic Business Report

  • PDF Icon

    Report

  • 182 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5141497
The global market for Vascular Imaging was estimated at US$8.6 Billion in 2023 and is projected to reach US$11.9 Billion by 2030, growing at a CAGR of 4.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Vascular Imaging Market - Key Trends & Drivers Summarized

What Is Driving the Adoption of Vascular Imaging Technologies?

Vascular imaging technologies have become indispensable in the diagnosis and management of vascular diseases, offering detailed visualizations of blood vessels and circulatory systems. The increasing prevalence of cardiovascular and peripheral vascular diseases has led to a surge in the demand for advanced imaging modalities such as ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA). These technologies provide critical insights into vascular conditions, enabling early diagnosis, precise treatment planning, and effective monitoring of disease progression. As healthcare providers strive to improve patient outcomes and reduce the burden of vascular diseases, the adoption of vascular imaging technologies is expected to grow, driving market expansion.

How Are Technological Advancements Enhancing Vascular Imaging?

Technological advancements have significantly enhanced the capabilities of vascular imaging, making it more accurate, non-invasive, and accessible. The development of high-resolution imaging systems and contrast agents has improved the clarity and detail of vascular images, allowing for better detection of abnormalities and blockages. The integration of artificial intelligence (AI) and machine learning algorithms into imaging systems has further revolutionized the field, enabling automated image analysis and predictive diagnostics. Additionally, innovations in portable and point-of-care imaging devices have made vascular imaging more accessible, particularly in remote or underserved regions. These technological advancements are driving the widespread adoption of vascular imaging technologies, as they offer greater precision and convenience in the diagnosis and management of vascular diseases.

What Are the Emerging Trends in Vascular Imaging?

The vascular imaging market is witnessing several emerging trends that are shaping its growth and development. One notable trend is the increasing use of hybrid imaging techniques, such as PET/CT and PET/MRI, which combine the strengths of different imaging modalities to provide more comprehensive and accurate assessments of vascular conditions. Another trend is the growing emphasis on non-invasive imaging methods, driven by the need to reduce patient discomfort and the risk of complications associated with invasive procedures. The rise in demand for personalized medicine is also influencing the market, as imaging technologies are increasingly being used to tailor treatment plans based on individual patient profiles. Furthermore, the expanding use of AI-driven imaging analytics is enabling more precise and faster interpretation of vascular images, improving diagnostic accuracy and efficiency.

What Factors Are Driving the Growth of the Vascular Imaging Market?

The growth in the vascular imaging market is driven by several factors, including the rising prevalence of vascular diseases such as atherosclerosis, aneurysms, and deep vein thrombosis. The increasing demand for early and accurate diagnosis, fueled by the growing awareness of the importance of preventive healthcare, is also a significant driver. Additionally, the continuous advancements in imaging technologies, including the development of more sophisticated and non-invasive imaging systems, are expanding the range of diagnostic options available to healthcare providers. The shift towards value-based care, which emphasizes the importance of accurate diagnostics in improving patient outcomes and reducing healthcare costs, is further boosting the adoption of vascular imaging technologies. Moreover, the growing focus on research and development in the field of vascular imaging, supported by government initiatives and funding, is contributing to the market's growth.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the MRI segment, which is expected to reach US$5.5 Billion by 2030 with a CAGR of a 4.8%. The CT segment is also set to grow at 4.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $2.3 Billion in 2023, and China, forecasted to grow at an impressive 8.3% CAGR to reach $2.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Vascular Imaging Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vascular Imaging Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Vascular Imaging Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, Carestream Health, Inc., Esaote SpA, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 18 Featured):

  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Vascular Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Non-invasive Imaging Techniques
  • Technological Advancements in Vascular Ultrasound
  • Growth of MRI and CT Angiography in Vascular Diagnostics
  • Adoption of AI and Machine Learning in Vascular Imaging Analysis
  • Increasing Use of Portable and Handheld Imaging Devices
  • Expanding Applications of Vascular Imaging in Disease Screening
  • Innovations in Contrast Media and Imaging Agents
  • Integration of Imaging with Vascular Interventional Procedures
  • Growing Awareness and Early Diagnosis of Vascular Conditions
  • Cost-effectiveness and Accessibility of New Imaging Modalities
  • Rising Prevalence of Cardiovascular Diseases Globally
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for X-Ray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for X-Ray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for X-Ray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Nuclear Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 19: World Vascular Imaging Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
CANADA
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
JAPAN
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
CHINA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 44: China Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: China 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 47: China Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: China 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
EUROPE
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
FRANCE
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 59: France Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: France 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 62: France Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: France 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
GERMANY
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
ITALY
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 77: UK Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 80: UK Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
SPAIN
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Spain 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 86: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Spain Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Spain 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
RUSSIA
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Russia 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 92: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Russia Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Russia 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
REST OF EUROPE
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Rest of Europe 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Rest of Europe Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Rest of Europe 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Vascular Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
  • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Asia-Pacific Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: Asia-Pacific 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
AUSTRALIA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation

Table Information